 | Up a level |
Lestner, J, McEntee, L, Johnson, A 
ORCID: 0000-0002-6684-3321, Livermore, J, Whalley, S, Schwartz, J, Perfect, JR, Harrison, T and Hope, W ORCID: 0000-0001-6187-878X
(2017)
Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis.
Antimicrobial agents and chemotherapy, 61 (06).
Oliver, JD, Sibley, GEM, Beckmann, N, Dobb, KS, Slater, MJ, McEntee, L, du Pre, S, Livermore, J, Bromley, MJ, Wiederhold, NP et al (show 4 more authors)
(2016)
F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113 (45).
pp. 12809-12814.
Negri, CE, Johnson, A ORCID: 0000-0002-6684-3321, McEntee, L, Box, H, Whalley, S, Schwartz, JA, Ramos-Martín, V, Livermore, J, Kolamunnage-Dona, R ORCID: 0000-0003-3886-6208, Colombo, AL et al (show 1 more authors)
(2018)
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.
The Journal of infectious diseases, 217 (7).
pp. 1118-1127.
Hope, WW ORCID: 0000-0001-6187-878X, McEntee, L, Livermore, J, Whalley, S, Johnson, A ORCID: 0000-0002-6684-3321, Farrington, N, Kolamunnage-Dona, R ORCID: 0000-0003-3886-6208, Schwartz, J, Kennedy, A, Law, D et al (show 2 more authors)
(2017)
Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease.
mBio, 8 (4).
e01157-e01117.